Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).

Singh, Jasvinder A; Hossain, Alomgir; Tanjong Ghogomu, Elizabeth; Mudano, Amy S; Tugwell, Peter; Wells, George A

Singh, Jasvinder A; Hossain, Alomgir; Tanjong Ghogomu, Elizabeth; Mudano, Amy S; Tugwell, Peter; Wells, George A.

Affiliation

Singh JA; Department of Medicine, Birmingham VA Medical Center, Faculty Office Tower 805B, 510 20th Street South, Birmingham, AL, USA, 35294.

Cochrane Database Syst Rev ; 11: CD012437, 2016 11 17.

Article in En | MEDLINE | ID: mdl-27855242

Subject(s)

Antirheumatic Agents/therapeutic use; Biological Products/therapeutic use; Piperidines/therapeutic use; Pyrimidines/therapeutic use; Pyrroles/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Arthritis, Rheumatoid/drug therapy; Certolizumab Pegol/therapeutic use; Disease Progression; Etanercept/therapeutic use; Humans; Interleukin 1 Receptor Antagonist Protein/therapeutic use; Methotrexate/therapeutic use; Network Meta-Analysis; Rituximab/therapeutic use; Treatment Failure

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Pyrroles / Biological Products / Antirheumatic Agents Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Cochrane Database Syst Rev Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2016 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google